APOE and metabolic dysfunction-associated steatotic liver disease: The phenotypic spectrum of non-alcoholic fatty liver disease (NAFLD) and ApoE was described by Meroni et al. [65] in a 40y old female with early NAFLD and severe hypertriglyceridemia.